Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.44 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | CFD | P00746 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | ELANE | P08246 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14710190 | 0.95 | LMNA (0.46) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL5534885 | 0.93 | LMNA (0.45) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL10765006 | 0.92 | KMT2A (0.44) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL27725727 | 0.87 | CYP3A4 (0.53) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL2010436 | 0.87 | LMNA (0.59) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL13141031 | 0.87 | LMNA (0.53) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL4563723 | 0.86 | LMNA (0.40) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL16952030 | 0.86 | CTSL (0.41) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL903399 | 0.86 | CYP4F2 (0.59) | LMNAMAPTKDM4ECYP3A4MEN1 | |
| SCHEMBL16960965 | 0.86 | LMNA (0.40) | LMNAMAPTKDM4ECYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10000604-B2 | Polymer and compensation film and optical film and display device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-06-19 | — | — | US | disclosed |
| US-20170183446-A1 | POLYMER AND COMPENSATION FILM AND OPTICAL FILM AND DISPLAY DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
| US-20170183446-A1 | POLYMER AND COMPENSATION FILM AND OPTICAL FILM AND DISPLAY DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
| CN-101117317-B | Process for the preparation of stilbene derivatives | DSM IP ASSETS BV | 2011-10-12 | — | — | CN | disclosed |
| US-7820848-B2 | Process for the preparation of stilbene derivatives | DSM IP ASSETS B.V. (NL) | 2010-10-26 | — | — | US | disclosed |
| CN-101117317-A | Process for the preparation of stilbene derivatives | DSM IP ASSETS BV (NL) | 2008-02-06 | — | — | CN | disclosed |
| CN-100348564-C | Process for preparing stilbene derivatives | DSM IP ASSETS BV (NL) | 2007-11-14 | — | — | CN | disclosed |
| US-20070197819-A1 | Process for the preparation of stilbene derivatives | DSM IP ASSETS B.V. (NL) | 2007-08-23 | — | — | US | disclosed |
| CN-1845889-A | Process for preparing stilbene derivatives | DSM IP ASSETS BV (NL) | 2006-10-11 | — | — | CN | disclosed |
| EP-1663926-A2 | PROCESS FOR THE PREPARATION OF STILBENE DERIVATIVES | DSM IP Assets B.V. (NL) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005023740-A2 | PROCESS FOR THE PREPARATION OF STILBENE DERIVATIVES | DSM IP ASSETS B.V. (NL) | 2005-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197819-A1 | Process for the preparation of stilbene derivatives | VRK1, HPD, SIK1 | LMNA 2910/4885MAPT 2686/4885KDM4E 818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.